Our committees are at the forefront of change and debate

This committee focuses on issues related to the financing of healthcare. This includes how resources are currently allocated, the sufficiency of these in achieving UHC, the impact on affordability and issues related to private financing, such as health insurance and private health investment.

This committee addresses the many complex issues involved in payor-provider relationships.  This includes 

quality monitoring and management across providers and payors, pricing and new models of contracting, data transparency and reporting across organizational boundaries  and the development of new, joint service offerings.

This committee supports members to explore transformational developments occurring in the digital health space. The committee explores the impact of these new technologies on care models and what this means for how services could be organized, financed and delivered. The committee also looks at the development of data analytics and its applications for healthcare.

The work of this committee focuses on the market environment for health investing and deal creation. This spans capital markets, FDI regulation as well as VC/PE and development/impact investing. 

The committee focuses on all aspects of healthcare infrastructure development, including the design, financing and operation of new/upgraded facilities. 

This committee deals with the myriad of issues related to the recruitment, retention and training of skilled, quality healthcare workers. Given the global workforce shortage, this committee is particularly important in advancing new ideas on meeting tomorrow's resourcing needs. 

The China committee focuses on major developments and reforms taking place in the PRC, and the implications and opportunities these present to business. This includes opportunities presented by the GBA 

This committee is a forum to discuss solutions to the ever-growing problem of non-communicable disease development.  This includes both cross-cutting system solutions, and disease-specific challenges presented by major issues such as oncology and diabetes

The Southeast Asia committee focuses on healthcare challenges across Asia's emerging markets. This includes market developments and regulations, advances in UHC and the advancement of quality healthcare in the region.